Myeloma: OBI Rivals IV Isatuximab, Ups Patient Comfort ...Middle East

Medscape - News
Myeloma: OBI Rivals IV Isatuximab, Ups Patient Comfort
IRAKLIA, the first phase 3 multiple myeloma study to use an on-body injector, finds the same efficacy and pharmacokinetics in isatuximab, with many fewer infusion reactions. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Myeloma: OBI Rivals IV Isatuximab, Ups Patient Comfort )

Apple Storegoogle play

Also on site :